Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qimin Zhan

Showing results (81-90 of 242) with videos related to

Pageof 25
Sort By:
Clinical and Translational Medicine|August 30, 2021
NOX5 mediates the crosstalk between tumor cells and cancer-associated fibroblasts via regulating cytokine networkJie Chen, Yan Wang, Weimin Zhang, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|February 22, 2024
Tumor-associated macrophage (TAM)-secreted CCL22 confers cisplatin resistance of esophageal squamous cell carcinoma (ESCC) cells via regulating the activity of diacylglycerol kinase α (DGKα)/NOX4 axisJie Chen, Di Zhao, Lingyuan Zhang, et al.
Nature Genetics|November 26, 2002
The mismatch repair system is required for S-phase checkpoint activationKevin D Brown, Abhilasha Rathi, Ravindra Kamath, et al.
Oncogene|August 1, 2002
Caspase-3 mediated cleavage of BRCA1 during UV-induced apoptosisQimin Zhan, Shunqian Jin, Bobby Ng, et al.
Molecular Carcinogenesis|May 21, 2021
Feed-forward activation of STAT3 signaling limits the efficacy of c-Met inhibitors in esophageal squamous cell carcinoma (ESCC) treatmentDi Zhao, Jie Chen, Yan Wang, et al.
Plos One|June 25, 2014
Receptor interactive protein kinase 3 promotes Cisplatin-triggered necrosis in apoptosis-resistant esophageal squamous cell carcinoma cellsYang Xu, Zhengwei Lin, Nan Zhao, et al.
The Journal of Molecular Diagnostics : JMD|August 28, 2012
Inhibition of SOX17 by microRNA 141 and methylation activates the WNT signaling pathway in esophageal cancerYan Jia, Yunsheng Yang, Qimin Zhan, et al.
JCI Insight|September 8, 2021
Genomic and epigenomic evolution of acquired resistance to combination therapy in esophageal squamous cell carcinomaQingjie Min, Yan Wang, Qingnan Wu, et al.
Acta Pharmaceutica Sinica. B|March 6, 2023
PAFR/Stat3 axis maintains the symbiotic ecosystem between tumor and stroma to facilitate tumor malignancyDi Zhao, Jing Zhang, Lingyuan Zhang, et al.
Cancer Biology & Therapy|February 17, 2006
Administration of PUMA adenovirus increases the sensitivity of esophageal cancer cells to anticancer drugsHaijuan Wang, Haili Qian, Jian Yu, et al.
Pageof 25

Showing results (81-90 of 242) with videos related to

Sort By:
Pageof 25
Clinical and Translational Medicine|August 30, 2021
NOX5 mediates the crosstalk between tumor cells and cancer-associated fibroblasts via regulating cytokine networkJie Chen, Yan Wang, Weimin Zhang, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|February 22, 2024
Tumor-associated macrophage (TAM)-secreted CCL22 confers cisplatin resistance of esophageal squamous cell carcinoma (ESCC) cells via regulating the activity of diacylglycerol kinase α (DGKα)/NOX4 axisJie Chen, Di Zhao, Lingyuan Zhang, et al.
Nature Genetics|November 26, 2002
The mismatch repair system is required for S-phase checkpoint activationKevin D Brown, Abhilasha Rathi, Ravindra Kamath, et al.
Oncogene|August 1, 2002
Caspase-3 mediated cleavage of BRCA1 during UV-induced apoptosisQimin Zhan, Shunqian Jin, Bobby Ng, et al.
Molecular Carcinogenesis|May 21, 2021
Feed-forward activation of STAT3 signaling limits the efficacy of c-Met inhibitors in esophageal squamous cell carcinoma (ESCC) treatmentDi Zhao, Jie Chen, Yan Wang, et al.
Plos One|June 25, 2014
Receptor interactive protein kinase 3 promotes Cisplatin-triggered necrosis in apoptosis-resistant esophageal squamous cell carcinoma cellsYang Xu, Zhengwei Lin, Nan Zhao, et al.
The Journal of Molecular Diagnostics : JMD|August 28, 2012
Inhibition of SOX17 by microRNA 141 and methylation activates the WNT signaling pathway in esophageal cancerYan Jia, Yunsheng Yang, Qimin Zhan, et al.
JCI Insight|September 8, 2021
Genomic and epigenomic evolution of acquired resistance to combination therapy in esophageal squamous cell carcinomaQingjie Min, Yan Wang, Qingnan Wu, et al.
Acta Pharmaceutica Sinica. B|March 6, 2023
PAFR/Stat3 axis maintains the symbiotic ecosystem between tumor and stroma to facilitate tumor malignancyDi Zhao, Jing Zhang, Lingyuan Zhang, et al.
Cancer Biology & Therapy|February 17, 2006
Administration of PUMA adenovirus increases the sensitivity of esophageal cancer cells to anticancer drugsHaijuan Wang, Haili Qian, Jian Yu, et al.
Pageof 25